Accessibility Menu
 
U.s. Stem Cell logo

U.s. Stem Cell

(OTC) USRM

Current Price$0.00
Market Cap$64,200
Since IPO (2008)-100%
5 Year-100%
1 Year+0%
1 Month+9,900%

U.s. Stem Cell Financials at a Glance

Market Cap

$64,200

Revenue (TTM)

$82.05K

Net Income (TTM)

$2.86M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-51.66 (Low)

Price

$0.00

Volume

4

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

USRM News

No articles available.

USRM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About U.s. Stem Cell

Industry

Biotechnology

CEO

Miguel Tomás, MBA

Headquarters

Sunrise, FL 33323, US

USRM Financials

Key Financial Metrics (TTM)

Gross Margin

71%

Operating Margin

-21%

Net Income Margin

-35%

Return on Equity

0%

Return on Capital

12%

Return on Assets

-42%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$64.20K

Shares Outstanding

641.51M

Volume

4

Short Interest

0.00%

Avg. Volume

137.35K

Financials (TTM)

Gross Profit

$58.28K

Operating Income

$1.72M

EBITDA

$2.17M

Operating Cash Flow

$304.85K

Capital Expenditure

$0.00

Free Cash Flow

$304.85K

Cash & ST Invst.

$5.13K

Total Debt

$8.95M

U.s. Stem Cell Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2022YOY CHG

Revenue

$19.97K

-15.3%

Gross Profit

$15.05K

+0.6%

Gross Margin

75.36%

N/A

Market Cap

$64.20K

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$566.62K

+11.6%

EBITDA

$374.92K

-199.7%

Quarterly Fundamentals

Name
Q4 2022YOY CHG

Net Cash

$8.94M

-12.1%

Accounts Receivable

$4.33K

+257.1%

Inventory

$980.00

+149.4%

Long Term Debt

$682.04K

-5.5%

Short Term Debt

$8.26M

+13.4%

Return on Assets

-42.00%

N/A

Return on Invested Capital

12.28%

N/A

Free Cash Flow

$43.06K

+80.1%

Operating Cash Flow

$43.06K

+80.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
REFGMedical Cannabis Payment Solutions, Inc.
$0.00+0.00%
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
MRPIMera Pharmaceuticals, Inc.
$0.00+0.00%
BSSPBaseline Productions, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
RITMRithm Capital
$8.77-0.03%

Questions About USRM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.